Search

If Poor Countries Go Unvaccinated, a Study Says, Rich Ones Will Pay - The New York Times

sinayamars.blogspot.com

A failure to distribute the Covid-19 vaccine in poor nations will worsen economic damage, with half the costs borne by wealthy countries, new research shows.

In monopolizing the supply of vaccines against Covid-19, wealthy nations are threatening more than a humanitarian catastrophe: The resulting economic devastation will hit affluent countries nearly as hard as those in the developing world.

This is the crucial takeaway from an academic study to be released on Monday. In the most extreme scenario — with wealthy nations fully vaccinated by the middle of this year, and poor countries largely shut out — the study concludes that the global economy would suffer losses exceeding $9 trillion, a sum greater than the annual output of Japan and Germany combined.

Nearly half of those costs would be absorbed by wealthy countries like the United States, Canada and Britain.

In the scenario that researchers term most likely, in which developing countries vaccinate half their populations by the end of the year, the world economy would still absorb a blow of between $1.8 trillion and $3.8 trillion. More than half of the pain would be concentrated in wealthy countries.

Commissioned by the International Chamber of Commerce, the study concludes that equitable distribution of vaccines is in every country’s economic interest, especially those that depend most on trade. It amounts to a rebuke to the popular notion that sharing vaccines with poor countries is merely a form of charity.

“Clearly, all economies are connected,” said Selva Demiralp, an economist at Koc University in Istanbul who previously worked at the Federal Reserve in Washington, and one of study’s authors. “No economy will be fully recovered unless the other economies are recovered.”

Ms. Demiralp noted that a global philanthropic initiative known as the ACT Accelerator — which is aimed at providing pandemic resources to developing countries — has secured commitments for less than $11 billion toward a $38 billion target. The study lays out the economic rationale for closing the gap. The remaining $27 billion may, on its face, look like an enormous sum, but is a pittance compared with the costs of allowing the pandemic to carry on.

The commonplace idea that the pandemic respects neither borders nor racial and class divides has been promoted by corporate chief executives and pundits. This comforting concept has been belied by the reality that Covid-19 has trained its death and destruction of livelihoods on low-wage service workers, and especially racial minorities, while white-collar employees have been able to largely work safely from home, and some of the world’s wealthiest people can ride out the pandemic on yachts and private islands.

But in the realm of international commerce, there is no hiding from the coronavirus, as the study brings home. Instead, there are global supply chains that produce the piece parts for industry, and that will continue to be disrupted so long as the virus remains a force.

The loss of jobs for migrant workers from poor countries has reduced the amount of money they have sent home.
Marco Bello/Reuters

A team of economists affiliated with Koc University, Harvard University and the University of Maryland examined trade data across 35 industries in 65 countries, producing an extensive exploration of the economic impacts of unequal vaccine distribution.

Covid-19 Vaccines ›

Answers to Your Vaccine Questions

While the exact order of vaccine recipients may vary by state, most will likely put medical workers and residents of long-term care facilities first. If you want to understand how this decision is getting made, this article will help.

Life will return to normal only when society as a whole gains enough protection against the coronavirus. Once countries authorize a vaccine, they’ll only be able to vaccinate a few percent of their citizens at most in the first couple months. The unvaccinated majority will still remain vulnerable to getting infected. A growing number of coronavirus vaccines are showing robust protection against becoming sick. But it’s also possible for people to spread the virus without even knowing they’re infected because they experience only mild symptoms or none at all. Scientists don’t yet know if the vaccines also block the transmission of the coronavirus. So for the time being, even vaccinated people will need to wear masks, avoid indoor crowds, and so on. Once enough people get vaccinated, it will become very difficult for the coronavirus to find vulnerable people to infect. Depending on how quickly we as a society achieve that goal, life might start approaching something like normal by the fall 2021.

Yes, but not forever. The two vaccines that will potentially get authorized this month clearly protect people from getting sick with Covid-19. But the clinical trials that delivered these results were not designed to determine whether vaccinated people could still spread the coronavirus without developing symptoms. That remains a possibility. We know that people who are naturally infected by the coronavirus can spread it while they’re not experiencing any cough or other symptoms. Researchers will be intensely studying this question as the vaccines roll out. In the meantime, even vaccinated people will need to think of themselves as possible spreaders.

The Pfizer and BioNTech vaccine is delivered as a shot in the arm, like other typical vaccines. The injection won’t be any different from ones you’ve gotten before. Tens of thousands of people have already received the vaccines, and none of them have reported any serious health problems. But some of them have felt short-lived discomfort, including aches and flu-like symptoms that typically last a day. It’s possible that people may need to plan to take a day off work or school after the second shot. While these experiences aren’t pleasant, they are a good sign: they are the result of your own immune system encountering the vaccine and mounting a potent response that will provide long-lasting immunity.

No. The vaccines from Moderna and Pfizer use a genetic molecule to prime the immune system. That molecule, known as mRNA, is eventually destroyed by the body. The mRNA is packaged in an oily bubble that can fuse to a cell, allowing the molecule to slip in. The cell uses the mRNA to make proteins from the coronavirus, which can stimulate the immune system. At any moment, each of our cells may contain hundreds of thousands of mRNA molecules, which they produce in order to make proteins of their own. Once those proteins are made, our cells then shred the mRNA with special enzymes. The mRNA molecules our cells make can only survive a matter of minutes. The mRNA in vaccines is engineered to withstand the cell's enzymes a bit longer, so that the cells can make extra virus proteins and prompt a stronger immune response. But the mRNA can only last for a few days at most before they are destroyed.

If people in developing countries remain out of work because of lockdowns required to choke off the spread of the virus, they will have less money to spend, reducing sales for exporters in North America, Europe and East Asia. Multinational companies in advanced nations will also struggle to secure required parts, components and commodities.

At the center of the story is the reality that most international trade involves not finished wares but parts that are shipped from one country to another to be folded into products. Of the $18 trillion worth of goods that were traded last year, so-called intermediate goods represented $11 trillion, according to the Organization for Economic Cooperation and Development.

The study finds that the continued pandemic in poor countries is likely to be worst for industries that are especially dependent on suppliers around the world, among them automotive, textiles, construction and retail, where sales could decline more than 5 percent.

The findings add a complicating layer to the basic assumption that the pandemic will leave the world economy more unequal than ever. While this appears true, one striking form of inequality — access to vaccines — could pose universal problems.

In an extraordinary testament to the innovative capacities of the world’s most skilled scientists, some of the leading pharmaceutical companies produced lifesaving vaccines in a small fraction of the time thought possible. But the wealthiest countries in North America and Europe locked up orders for most of the supply — enough to vaccinate two and three times their populations — leaving poor countries scrambling to secure their share.

Many developing countries, from Bangladesh to Tanzania to Peru, will likely have to wait until 2024 before fully vaccinating their populations.

The initiative to supply poor countries with additional resources gained a boost as President Biden took office. The Trump administration did not contribute to the cause. Mr. Biden’s chief medical officer for the pandemic, Dr. Anthony S. Fauci, promptly announced that the United States would join the campaign to share vaccines.

In contrast to the trillions of dollars that governments in wealthy countries have spent to rescue companies and workers harmed by the health emergency and the wrenching economic downturn, developing countries have struggled to respond.

As migrant workers from poor countries have lost jobs during the pandemic, they have not been able to send as much money home, leveling a major blow to countries that have relied on these so-called remittances like the Philippines, Pakistan and Bangladesh.

The global recession has slashed demand for commodities, decimating copper producers like Zambia and the Democratic Republic of Congo, and countries dependent on oil like Angola and Nigeria. As Covid-19 cases have soared, that has depressed tourism, costing jobs and revenue in Thailand, Indonesia and Morocco.

Athit Perawongmetha/Reuters

Many poor countries entered the pandemic with debt burdens that absorbed much of their government revenue, limiting their spending on health care. Private creditors have refused to participate in a modest debt suspension program forged by the Group of 20. The World Bank and the International Monetary Fund both promised major relief but failed to produce significant dollars.

This, too, appears to be changing as new leadership takes over Washington. The Trump administration opposed a proposed $500 million expansion of so-called special drawing rights at the I.M.F., a reserve asset that governments can exchange for hard currency. Mr. Biden’s ascent has bolstered hopes among fund members that his administration will support the expansion. Democrats in Congress — now in control of both chambers — have signaled support for a measure that would compel the Treasury to act.

Still, in capitals like Washington and Brussels, the discussion about support for the developing world has been framed in moral terms. Leaders have debated how much they can spare to help the planet’s least fortunate communities while mostly tending to their own people.

The study challenges that frame. In failing to ensure that people in the developing world gain access to vaccines, it concludes, leaders in the wealthiest nations are damaging their own fortunes.

“No economy, however big, will be immune to the effects of the virus until the pandemic is brought to an end everywhere,” said John Denton, secretary general of the International Chamber of Commerce. “Purchasing vaccines for the developing world isn’t an act of generosity by the world’s richest nations. It’s an essential investment for governments to make if they want to revive their domestic economies.”

Let's block ads! (Why?)



"pay" - Google News
January 23, 2021 at 05:00PM
https://ift.tt/2LYresL

If Poor Countries Go Unvaccinated, a Study Says, Rich Ones Will Pay - The New York Times
"pay" - Google News
https://ift.tt/301s6zB


Bagikan Berita Ini

0 Response to "If Poor Countries Go Unvaccinated, a Study Says, Rich Ones Will Pay - The New York Times"

Post a Comment

Powered by Blogger.